Tilray Brands (TLRY) Interest Expenses (2017 - 2026)
Tilray Brands (TLRY) posted Interest Expenses of $28.6 million for Q1 2026, down 6.25% on a QoQ basis from $30.5 million in Q4 2025, and down 60.0% year-over-year from $71.5 million in Q1 2025.
Tilray Brands (TLRY) Interest Expenses (2017 - 2026) Analysis & Trends
Tilray Brands' Interest Expenses history runs 10 years deep, the most recent figure standing at $28.6 million for Q1 2026.
- Quarterly Interest Expenses fell 60.0% year-over-year to $28.6 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $28.6 million (down 60.0% YoY) and the FY2025 annual result came in at $968.9 million, up 22.67% from the prior year.
- Interest Expenses was $28.6 million for Q1 2026 at Tilray Brands, down from $30.5 million in the prior quarter.
- Across five years, Interest Expenses topped out at $74.4 million in Q3 2024 and bottomed at $2.9 million in Q3 2025.
- A 5-year average of $47.3 million and a median of $42.5 million in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 2057.33% — and 2025, when it sank 96.11%.
- Tilray Brands' Interest Expenses stood at $59.2 million in 2022, then climbed by 24.52% to $73.7 million in 2023, then dropped by 1.47% to $72.6 million in 2024, then slumped by 58.0% to $30.5 million in 2025, then slipped by 6.25% to $28.6 million in 2026.
- Business Quant data shows TLRY's Interest Expenses at $28.6 million in Q1 2026, $30.5 million in Q4 2025, and $2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 28.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 28.61 Mn |
| Feb 28, 2026 | 28.61 Mn |
| Nov 30, 2025 | 30.51 Mn |
| Nov 30, 2025 | 30.51 Mn |
| Aug 31, 2025 | 2.90 Mn |
| Aug 31, 2025 | 2.90 Mn |
| May 31, 2025 | 35.00 Mn |
| May 31, 2025 | 35.00 Mn |
| Feb 28, 2025 | 71.52 Mn |
| Feb 28, 2025 | 71.52 Mn |
| Nov 30, 2024 | 72.64 Mn |
| Nov 30, 2024 | 72.64 Mn |
| Aug 31, 2024 | 74.43 Mn |
| Aug 31, 2024 | 74.43 Mn |
| May 31, 2024 | 42.54 Mn |
| May 31, 2024 | 42.54 Mn |
| Feb 29, 2024 | 73.44 Mn |
| Feb 29, 2024 | 73.44 Mn |
| Nov 30, 2023 | 73.72 Mn |
| Nov 30, 2023 | 73.72 Mn |